№ files_lp_3_process_7_059415
File format: docx Character count: 110642 File size: 499 KB
Gemtuzumab ozogamicin in combination with standard chemotherapy is evaluated for its efficacy in treating acute myeloid leukaemia (AML) in patients with favourable/intermediate/unknown cytogenetic risk.
Year: 2020
Region / city: Australia
Therapeutic area: Oncology
Document type: Regulatory submission
Institution: Pfizer Australia Pty Ltd.
Author: Pfizer Australia Pty Ltd.
Target audience: Regulatory authorities, medical professionals
Effective period: Ongoing
Approval date: April 9, 2020
Date of last revision: March 2021
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.